InvestSMART

Alterity Therapeutics Limited (ASX: ATH) - Announcements

Current share price for ATH : $0.240 0.025 (9.43%)+

ASX company news and announcements for Alterity Therapeutics Limited (ATH) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Alterity Therapeutics Limited (ATH) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Alterity Therapeutics Limited (ATH), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Alterity Therapeutics Limited (ATH)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$55 ATH Shareholder Letter January 2026 21 Jan 2026 10:14AM $0.008 $0.240 risen by 2,900%
$55 Notification regarding unquoted securities - ATH 15 Jan 2026 12:52PM $0.008 $0.240 risen by 2,900%
$55 Notification regarding unquoted securities - ATH 15 Jan 2026 12:23PM $0.008 $0.240 risen by 2,900%
$55 Corporate Presentation 13 Jan 2026 10:49AM $0.008 $0.240 risen by 2,900%
$55 Change of Director's Interest Notice - D Stamler 7 Jan 2026 11:31AM $0.009 $0.240 risen by 2,566.67%
$55 Notification of cessation of securities - ATH 7 Jan 2026 11:08AM $0.009 $0.240 risen by 2,566.67%
$55 Initial Director's Interest Notice - Barbaczy 24 Nov 2025 3:48PM $0.009 $0.240 risen by 2,566.67%
$55 Initial Director's Interest Notice - Stamler 24 Nov 2025 3:47PM $0.009 $0.240 risen by 2,566.67%
$55 Final Director's Interest Notice - Meltzer 24 Nov 2025 1:07PM $0.010 $0.240 risen by 2,300%
$55 Final Director's Interest Notice - Kempler 24 Nov 2025 1:06PM $0.010 $0.240 risen by 2,300%
$55 Results of Meeting 21 Nov 2025 12:48PM $0.009 $0.240 risen by 2,566.67%
$55 Presentation to Annual General Meeting 21 Nov 2025 10:45AM $0.009 $0.240 risen by 2,566.67%
$55 Chairman's Address 2025 Annual General Meeting 21 Nov 2025 10:35AM $0.009 $0.240 risen by 2,566.67%
$55 Alterity Board Changes 21 Nov 2025 9:20AM $0.009 $0.240 risen by 2,566.67%
$55 Disclosure under Takeovers Panel GN 20 13 Nov 2025 12:58PM $0.009 $0.240 risen by 2,566.67%
$55 Alterity to Present at the Bell Potter Healthcare Conference 12 Nov 2025 11:17AM $0.009 $0.240 risen by 2,566.67%
$55 Alterity Presents Promising ATH434 Impact at AAS Symposium 10 Nov 2025 10:41AM $0.009 $0.240 risen by 2,566.67%
$55 Quarterly Activities/Appendix 4C Cash Flow Report 31 Oct 2025 9:30AM $0.011 $0.240 risen by 2,081.82%
$55 Notice of Annual General Meeting/Proxy Form 21 Oct 2025 2:24PM $0.012 $0.240 risen by 1,900%
$55 Change in substantial holding 14 Oct 2025 4:50PM $0.011 $0.240 risen by 2,081.82%
$55 Alterity Presents Positive ATH434 Data at 2025 MDS Congress 9 Oct 2025 10:56AM $0.010 $0.240 risen by 2,300%
$55 Alterity to Deliver Multiple Presentations at MDS Conference 2 Oct 2025 8:32AM $0.009 $0.240 risen by 2,566.67%
$55 Alterity Reports New Commercial Assessment for ATH434 in MSA 29 Sep 2025 12:26PM $0.010 $0.240 risen by 2,300%
$55 Date of AGM and Closing Date for Director Nominations 23 Sep 2025 5:12PM $0.011 $0.240 risen by 2,081.82%
$55 Change of Director's Interest Notice x 4 17 Sep 2025 3:28PM $0.011 $0.240 risen by 2,185.71%

76 - 100 of 583 results

Page 4 of 24

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.